Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Optimer acquires license to Globo H vaccine

Oct. 3, 2002

Early phase III enrollment for extended-release Eligard

Oct. 3, 2002

Integrin antagonists covered by 3-Dimensional patent

Oct. 3, 2002

New metal complexes as prodrugs of antitumor compounds

Oct. 3, 2002

Geron receives award for ongoing development of telomerase inhibitors for cancer

Oct. 3, 2002

Benefit:risk ratio of tamoxifen for breast cancer prophylaxis evaluated in large trial

Oct. 3, 2002

Iseganan fails to meet primary endpoint in ulcerative oral mucositis phase III trial

Oct. 2, 2002

Orphan drug grant for Endostatin trial

Oct. 2, 2002

Idec gains license to develop HMN-214

Oct. 2, 2002

Vical updates progress of Leuvectin program

Oct. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...